CX DAILY

CX Daily: The Battle to Make Cancer’s ‘Living Drug’ Affordable

Published: Jan. 16, 2026 9:00 a.m. GMT+8

00:00

00:00/00:00

Listen to this article 1x

TOP STORIES

In Depth: The Battle to Make Cancer’s ‘Living Drug’ Affordable

When Yu Yonggang was diagnosed with an aggressive form of lymphoma in 2013, he began a grueling three-year journey through 15 rounds of intravenous chemotherapy and 20 courses of oral chemo. With his cancer recurring and his body ravaged, doctors gave him about six months to live.

FINANCE & ECONOMY

China Announces First Monetary Easing of 2026

Register to read this article for free.

Register

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Powerful Quake Strikes Off Japan

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: Chinese Local Governments Risk Replicating Mistakes of LGFVs

00:00

00:00/00:00

MOST POPULAR

1: Exclusive: Wingtech Chair Vows to Regain Control of Nexperia After 100-Day Standoff

2: Cover Story: Six Things to Know About the Fall of Cambodia’s Cybercrime Kingpin Chen Zhi

3: China to Eliminate Export Tax Rebates for Solar and Batteries by 2027

4: In Depth: China Reins In High-Cost Personal Lending as Risk Concerns Grow

5: China’s Top Cities Face Office Glut With Supply Doubling Demand in 2025

SPONSORED

OR